CareDx (CDNA) Q2 2026: EPS Beats by 59%, Revenue Tops $131M
As seen on the 24/7 Wall St. homepage on July 30, 2026.
CareDx demolished EPS expectations with a 59% beat and raised full-year guidance after Testing Services revenue surged 61% to $99.93 million, powered by accelerating molecular surveillance adoption and a strategic lab divestiture that swelled cash reserves to $373.6 million.
Continue ReadingShow less
CareDx reported Q2 2026 earnings per share of $0.37, well ahead of the $0.232 consensus estimate — a 59% beat that extended a strong run of outperformance. The company also cleared the revenue bar by a wide margin, posting $131.9 million against expectations of roughly $114 million, a 16% beat. Management followed the results by raising full-year guidance, signaling confidence that the momentum is sustainable.
The engine behind the quarter was Testing Services, where revenue surged 61% to $99.93 million. CareDx credited accelerating adoption of molecular surveillance — the use of advanced testing to monitor transplant patients for signs of organ rejection — as the primary driver. A strategic divestiture of a lab operation also reshaped the balance sheet, pushing cash reserves to $373.6 million and giving the company significant financial flexibility.
Disclosure
1 INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA( www.finra.org )/SIPC( www.sipc.org ). 2 The probability of a member receiving $3,000 is 0.028%. If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Members must fund their account with a minimum of $50.00 to qualify. The probability percentage is subject to decrease. Members are only eligible for the Stock Award promotion upon opening their first brokerage account; subsequent cash brokerage accounts are ineligible for the promo, including for members with multiple accounts. 3Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees. 4There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event.
SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $3,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now. (Sponsor)
Looking at the recent earnings history, CareDx has now beaten EPS estimates in seven of the last eight quarters, and the magnitude of the beats has grown. The Q1 2026 result of $0.34 against a $0.13 estimate and the Q2 2026 outcome suggest analysts have consistently underestimated the pace of the company's turnaround. How durable the molecular surveillance tailwind proves to be, and how CareDx deploys its expanded cash position, are the key factors to watch in the quarters ahead.
Mentioned: CDNA